You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Poly ICLC

Showing 1 - 25 of 439
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Glioblastoma Multiforme, Glioblastoma, Adult, Glioma of Brain Trial in Geneva (IMA950/Poly-ICLC, IMA950/Poly-ICLC and

Active, not recruiting
  • Glioblastoma Multiforme
  • +3 more
  • Geneva, Switzerland
    University Hospitals of Geneva
Dec 23, 2022

Anatomic Stage IV Breast Cancer AJCC v8, Metastatic Breast Carcinoma, Prognostic Stage IV Breast Cancer AJCC v8 Trial in Los

Recruiting
  • Anatomic Stage IV Breast Cancer AJCC v8
  • +5 more
  • Anti-CD40 Agonist Monoclonal Antibody CDX-1140
  • +3 more
  • Los Angeles, California
    USC/Norris Comprehensive Cancer Center
Jan 31, 2023

Prostate Cancer Trial in New York (Intratumoral (IT) Poly ICLC 0.5 mg, Intratumoral (IT) Poly ICLC 1.0 mg, Intramuscular (IM)

Completed
  • Prostate Cancer
  • Intratumoral (IT) Poly ICLC 0.5 mg
  • +3 more
  • New York, New York
    Icahn School of Medicine at Mount Sinai
Sep 8, 2022

Glioma, Malignant, Antigen-specific Vaccines, Individualized Treatment Trial in Shanghai (NeoPep Vaccine1 plus Poly-ICLC, NeoPep

Recruiting
  • Glioma, Malignant
  • +2 more
  • NeoPep Vaccine1 plus Poly-ICLC
  • NeoPep Vaccine2 plus Poly-ICLC
  • Shanghai, Shanghai, China
    Shanghai 10th People's Hospital
Oct 7, 2022

Brain Tumors Trial in San Diego, Atlanta (Poly ICLC)

Completed
  • Brain Tumors
  • Poly ICLC
  • San Diego, California
  • +1 more
Apr 20, 2022

Oligodendroglioma, Astrocytoma, Grade II, Glioma, Astrocytic Trial in San Francisco (GBM6-AD and poly-ICLC before and after

Active, not recruiting
  • Oligodendroglioma
  • +5 more
  • GBM6-AD and poly-ICLC before and after surgery
  • GBM6-AD and poly-ICLC after surgery only
  • San Francisco, California
    University of California
Sep 20, 2022

COVID - 19 Trial in Calgary (Poly-ICLC (Hiltonol®) or Placebo)

Recruiting
  • COVID - 19
  • Poly-ICLC (Hiltonol®) or Placebo
  • Calgary, Alberta, Canada
    Health Research Innovation Centre
Mar 31, 2022

Hepatocellular Carcinoma Trial in Taipei City (Poly ICLC)

Recruiting
  • Hepatocellular Carcinoma
  • Poly ICLC
  • Taipei City, Zhongzheng Dist, Taiwan
    NTUH
Mar 7, 2022

Epithelial Ovarian Cancer, Fallopian Tube Cancer, Primary Peritoneal Cancer Trial in New York (NY-ESO-1 OLP4, NY-ESO-1 OLP4 +

Completed
Has Results
  • Epithelial Ovarian Cancer
  • +2 more
  • NY-ESO-1 OLP4
  • +2 more
  • New York, New York
    Memorial Sloan-Kettering Cancer Center
Oct 3, 2022

NF1, Low-grade Glioma Trial in United States (Poly ICLC)

Recruiting
  • NF1
  • Low-grade Glioma
  • Poly ICLC
  • Birmingham, Alabama
  • +18 more
Jan 5, 2023

Malignant Pleural Mesothelioma Trial in New York (Safety, Expansion Cohort)

Recruiting
  • Malignant Pleural Mesothelioma
  • Safety
  • Expansion Cohort
  • New York, New York
    Icahn School of Medicine Mount Sinai
Mar 31, 2022

Stage IV NSCLC Trial in Houston (Poly ICLC, IVIG)

Not yet recruiting
  • Stage IV NSCLC
  • Houston, Texas
    Michael E. DeBakey VA Medical Center, Houston, TX
Sep 28, 2023

Pancreas Cancer, Pancreatic Cancer, Cancer of the Pancreas Trial in Saint Louis (Optimized neoantigen synthetic long peptide

Recruiting
  • Pancreas Cancer
  • +2 more
  • Optimized neoantigen synthetic long peptide vaccine
  • Poly-ICLC
  • Saint Louis, Missouri
    Washington University School of Medicine
Jan 23, 2023

Pancreatic Cancer Metastatic, Colorectal Cancer Metastatic Trial in Baltimore (Neoantigen Vaccine with Poly-ICLC adjuvant,

Not yet recruiting
  • Pancreatic Cancer Metastatic
  • Colorectal Cancer Metastatic
  • Baltimore, Maryland
    Sidney Kimmel Comprehensive Cancer Center
Aug 5, 2022

Pancreas Cancer, Pancreatic Cancer, Cancer of the Pancreas Trial in Saint Louis (biological, drug, procedure)

Recruiting
  • Pancreas Cancer
  • +2 more
  • Neoantigen Peptide Vaccine
  • +2 more
  • Baltimore, Maryland
  • +1 more
Mar 15, 2022

Anatomic Stage IV Breast Cancer AJCC v8, Clinical Stage III Cutaneous Melanoma AJCC v8, Clinical Stage IV Cutaneous Melanoma

Recruiting
  • Anatomic Stage IV Breast Cancer AJCC v8
  • +20 more
  • Neoantigen Peptide Vaccine
  • +2 more
  • Seattle, Washington
    Fred Hutch/University of Washington Cancer Consortium
Sep 7, 2022

Melanoma Trial in New York (DC Vaccine, Montanide Vaccine, Poly-ICLC)

Completed
  • Melanoma
  • DC Vaccine
  • +2 more
  • New York, New York
  • +1 more
Sep 13, 2022

High Risk Cancer, Pancreatic Cancer Trial in Baltimore (KRAS peptide vaccine)

Recruiting
  • High Risk Cancer
  • Pancreatic Cancer
  • KRAS peptide vaccine
  • Baltimore, Maryland
    Sidney Kimmel Comprehensive Cancer Center
Jun 1, 2022

Acute Myeloid Leukemia, Blasts 30 Percent or Less of Bone Marrow Nucleated Cells, Chronic Myelomonocytic Leukemia Trial in

Completed
  • Acute Myeloid Leukemia
  • +5 more
  • DEC-205/NY-ESO-1 Fusion Protein CDX-1401
  • +4 more
  • Buffalo, New York
    Roswell Park Cancer Institute
Oct 4, 2021

Non-Hodgkin's Lymphoma, Metastatic Breast Cancer, Head and Neck Squamous Cell Carcinoma Trial in New York (Pembrolizumab, Flt3L,

Recruiting
  • Non-Hodgkin's Lymphoma
  • +2 more
  • New York, New York
    Icahn School of Medicine at Mount Sinai
Oct 18, 2021

Unresectable or Metastatic Melanoma Trial in Australia, United States (Ipilimumab, NY-ESO-1 Protein Vaccine, NY-ESO-1 OLP4

Terminated
Has Results
  • Unresectable or Metastatic Melanoma
  • Ipilimumab
  • +3 more
  • New York, New York
  • +4 more
Oct 3, 2022

Recurrent Glioblastoma Trial in Los Angeles (biological, other, drug)

Recruiting
  • Recurrent Glioblastoma
  • Dendritic Cell Tumor Cell Lysate Vaccine
  • +3 more
  • Los Angeles, California
    UCLA / Jonsson Comprehensive Cancer Center
Mar 29, 2022

Triple Negative Breast Cancer, Triple Negative Breast Tumors, Triple-Negative Breast Cancer Trial (Personalized synthetic long

Withdrawn
  • Triple Negative Breast Cancer
  • +2 more
  • Personalized synthetic long peptide vaccine (Poly ICLC)
  • Poly ICLC
  • (no location specified)
Mar 9, 2022

Diffuse Hemispheric Glioma, H3 G34-Mutant Trial in Los Angeles (biological, procedure, drug)

Not yet recruiting
  • Diffuse Hemispheric Glioma, H3 G34-Mutant
  • Dendritic Cell Tumor Peptide Vaccine
  • +6 more
  • Los Angeles, California
    UCLA / Jonsson Comprehensive Cancer Center
Jul 13, 2022

Fallopian Tube Carcinoma, Ovarian Carcinoma, Primary Peritoneal Carcinoma Trial in Buffalo (biological, drug, other)

Completed
  • Fallopian Tube Carcinoma
  • +2 more
  • DEC-205/NY-ESO-1 Fusion Protein CDX-1401
  • +4 more
  • Buffalo, New York
    Roswell Park Cancer Institute
Jul 20, 2021